| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Rivastigmine 192 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Rivastigmine 396 microgram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Methoxsalen 20 microgram/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely sodium picosulfate 66.7 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely zoledronic acid 50 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Tretinoin 500 microgram/mL cutaneous solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely carbenoxolone 20 milligram/1 gram conventional release oral gel (clinical drug) |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely iloprost 10 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely alendronic acid (as alendronate sodium) 933 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
2 |
| Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Carmellose 166 mg/g oral paste |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| budesonid 160 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
2 |
| budesonid 160 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| budesonid 80 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
2 |
| budesonid 80 mikrogram/dos och formoterol 4,5 mikrogram/dos, inhalationspulver |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous gel |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely gentamicin (as gentamicin sulfate) 900 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely betamethasone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Sodium cromoglicate 800 microgram/actuation powder for inhalation |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Gentamicin (as gentamicin sulfate) 3 mg/g eye ointment |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely desloratadine 500 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fluocinolone acetonide 590 microgram/1 each prolonged-release ocular implant (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Fluticasone propionate 250 microgram/mL solution for inhalation |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Salbutamol 400 microgram/actuation powder for inhalation |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
3 |
| Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Alprostadil 20 microgram/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 150 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 30 microgram/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 500 microgram/mL and tetracaine 150 microgram/mL oral spray |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 80 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Lidocaine 50 microgram/mg cutaneous patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| peginterferon alfa-2b 50 mikrogram, pulver till injektionsvätska, lösning, förfylld penna |
Has presentation strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fluocinolone acetonide 100 microgram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Budesonide 50 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Beclometasone dipropionate 84 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Ciclesonide 50 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Olopatadine hydrochloride 665 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Budesonide 200 microgram/actuation solution for inhalation |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Cyanocobalamin 500 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely dihydroergotamine mesilate 500 microgram/1 actuation conventional release nasal spray (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Ipratropium bromide 42 microgram/actuation nasal spray |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| cetrimid 5 milligram/milliliter och klorhexidinglukonat (som klorhexidin) 500 mikrogram/milliliter, kutan lösning |
Has concentration strength numerator unit |
False |
mcg |
Inferred relationship |
Some |
1 |
| Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely paracetamol 24 milligram/1 milliliter and promethazine hydrochloride 300 microgram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
3 |
| Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
2 |
| Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |
| Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mcg |
Inferred relationship |
Some |
1 |